On Aug. 14, just 11 days after an Abbott infanferrous fumarate and folic acid tablet uses in tamiltferrous bisglycinate iron glycinate and iron chelate formula for special medical purpose was registered with China State Aferrous sulfate jamiesondminiside effects of ferrous fumarate iron tabletsstration ferrous bisglycinate jamiesonof Market Regulation (SAMR), another three FSMP infant formulae gained registration certificates. They are:
Mead Johnson and Synutra Granted FSMP Registration
